Mice Deficient in STAT1 but Not STAT2 or IRF9 Develop a Lethal CD4+ T-Cell-Mediated Disease following Infection with Lymphocytic Choriomeningitis Virus

Journal of Virology

Volumn 86, Issue 12, 2012, Pages 6932-6946

  Hofer, Markus J ^a,b   Manders, Wen Li ^a   Terry, Rachael ^a   Lim, Sue Ling ^a   King, Nicholas J C ^a   Campbell, Iain L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; MESSENGER RNA; STAT1 PROTEIN; STAT2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTERFERON GAMMA GENE; INTERLEUKIN 1 ALPHA GENE; INTERLEUKIN 1 BETA GENE; INTERLEUKIN 10 GENE; INTERLEUKIN 17 GENE; INTERLEUKIN 23P19 GENE; INTERLEUKIN 6 GENE; LETHALITY; LYMPHOCYTIC CHORIOMENINGITIS; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL FACTOR; T LYMPHOCYTE ACTIVATION; TRANSFORMING GROWTH FACTOR BETA GENE; TUMOR NECROSIS FACTOR GENE; VIRAL CLEARANCE; VIRUS LOAD; WILD TYPE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; INTERFERONS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

EID: 84864012520     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07147-11     Document Type: Article

References (112)

1. Ahmed R, Butler LD, Bhatti L. 1988. T4+T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102-2106.
2. Ahmed R, King CC, Oldstone MB. 1987. Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo. J. Virol. 61:1571-1576.
3. Aichele P, et al. 2006. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176:4525- 4529.
4. Allan JE, Doherty PC. 1990. Binding of monoclonal antibodies and T cell effector function in vivo. Hybridoma 9:9 -15.
5. Alsharifi M, Mullbacher A, Regner M. 2008. Interferon type I responses in primary and secondary infections. Immunol. Cell Biol. 86:239 -245.
6. Amadi-Obi A, et al. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13:711-718.
7. Ank N, et al. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501- 4509.
8. Ank N, West H, Paludan SR. 2006. IFN-lambda: novel antiviral cytokines. J. Interferon Cytokine Res. 26:373-379.
9. Asensio VC, Campbell IL. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71:7832- 7840.
10. Asensio VC, Kincaid C, Campbell IL. 1999. Chemokines and the inflammatory response to viral infection in the central nervous system with a focus on lymphocytic choriomeningitis virus. J. Neurovirol. 5:65-75.
11. Asselin-Paturel C, et al. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144 -1150.
12. Baenziger J, Hengartner H, Zinkernagel RM, Cole GA. 1986. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur. J. Immunol. 16:387-393.
13. Barber DL, et al. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682- 687.
14. Bartholdy C, Christensen JP, Wodarz D, Thomsen AR. 2000. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus. J. Virol. 74:10304 -10311.
15. Barton LL, Mets MB, Beauchamp CL. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am. J. Obstet. Gynecol. 187:1715- 1716.
16. Batten M, et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929 -936.
17. Bente DA, et al. 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84:11089 -11100.
18. Blackburn SD, et al. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10:29 -37.
19. Borden EC, et al. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6:975-990.
20. Byrne JA, Oldstone MB. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682- 686.
21. Caretto D, Katzman SD, Villarino AV, Gallo E, Abbas AK. 2010. Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. J. Immunol. 184:30 -34.
22. Chang JH, Kim YJ, Han SH, Kang CY. 2009. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROSmediated apoptosis. Eur. J. Immunol. 39:1241-1251.
23. Christensen JE, et al. 2009. Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokine-chemokinecytokine-chemokine cascade. J. Immunol. 182:1079 -1087.
24. Christensen JP, Marker O, Thomsen AR. 1994. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand. J. Immunol. 40:373-382.
25. Dalod M, et al. 2002. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-528.
26. Deibel R, Schryver GD. 1976. Viral antibody in the cerebrospinal fluid of patients with acute central nervous system infections. J. Clin. Microbiol. 3:397- 401.
27. Deibel R, Woodall JP, Decher WJ, Schryver GD. 1975. Lymphocytic choriomeningitis virus in man. Serologic evidence of association with pet hamsters. JAMA 232:501-504.
28. Diebold SS, et al. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324 -328.
29. Dixon JE, Allan JE, Doherty PC. 1987. The acute inflammatory process in murine lymphocytic choriomeningitis is dependent on Lyt-2+ immune T cells. Cell. Immunol. 107:8 -14.
30. Doherty PC, Allan JE, Lynch F, Ceredig R. 1990. Dissection of an inflammatory process induced by CD8+ T cells. Immunol. Today 11: 55-59.
31. Doherty PC, Ceredig R, Allan JE. 1988. Immunogenetic analysis of cellular interactions governing the recruitment of T lymphocytes and monocytes in lymphocytic choriomeningitis virus-induced immunopathology. Clin. Immunol. Immunopathol. 47:19 -26.
32. Doherty PC, Hou S, Southern PJ. 1993. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J. Neuroimmunol. 46:11-17.
33. Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443- 450.
34. Durbin JE, et al. 2002. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2944 -2952.
35. Ejrnaes M, et al. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203:2461-2472.
36. Fischer SA, et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249.
37. Fung-Leung WP, Kundig TM, Zinkernagel RM, Mak TW. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-1429.
38. Garcia-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879-882.
39. Gil MP, et al. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. U. S. A. 98:6680-6685.
40. Gil MP, Salomon R, Louten J, Biron CA. 2006. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107:987-993.
41. Gough DJ, Levy DE, Johnstone RW, Clarke CJ. 2008. IFNgamma signaling- does it mean JAK-STAT? Cytokine Growth Factor Rev. 19: 383-394.
42. Hahm B, Trifilo MJ, Zuniga EI, Oldstone MB. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22:247-257.
43. Haque SJ, Williams BR. 1994. Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-alpha. J. Biol. Chem. 269: 19523-19529.
44. Hashimoto K, et al. 2005. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116:550 -557.
45. Hobbs MV, et al. 1993. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol. 150:3602-3614.
46. Hofer MJ, Carter SL, Muller M, Campbell IL. 2008. Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-Armstrong. Viral Immunol. 21:425- 433.
47. Hofer MJ, Li W, Lim SL, Campbell IL. 2010. The type I interferonalpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. J. Neurosci. 30:1149 -1157.
48. Huang S, et al. 1993. Immune response in mice that lack the interferongamma receptor. Science 259:1742-1745.
49. Huber M, et al. 2008. IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 20:223-234.
50. Jung A, et al. 2008. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82:196 -206.
51. Kamperschroer C, Quinn DG. 2002. The role of proinflammatory cytokines in wasting disease during lymphocytic choriomeningitis virus infection. J. Immunol. 169:340 -349.
52. Kang SS, McGavern DB. 2008. Lymphocytic choriomeningitis infection of the central nervous system. Front. Biosci. 13:4529-4543.
53. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. 2003 4th STAT1-dependent innate immunity to a Norwalk-like virus. Science 299:1575-1578.
54. Kimura T, et al. 1996. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1:115-124.
55. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202:637- 650.
56. Lang PA, et al. 2010. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 52:25-32.
57. Lehmann-Grube F, Lohler J, Utermohlen O, Gegin C. 1993. Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+T lymphocytes because of disruption of the beta 2-microglobulin gene. J. Virol. 67:332-339.
58. Leist TP, Cobbold SP, Waldmann H, Aguet M, Zinkernagel RM. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278 -2281.
59. Li X, Leung S, Qureshi S, Darnell JE, Jr, Stark GR. 1996. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J. Biol. Chem. 271:5790 -5794.
60. Liu H, Leung BP. 2006. CD4+CD25+ regulatory T cells in health and disease. Clin. Exp. Pharmacol. Physiol. 33:519 -524.
61. Lledo L, Gegundez MI, Saz JV, Bahamontes N, Beltran M. 2003. Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents. J. Med. Virol. 70:273-275.
62. Louten J, van Rooijen N, Biron CA. 2006. Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection. J. Immunol. 177:3266 -3272.
63. Ma H, et al. 2011. Absence of Stat1 in donor CD4 T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice. J. Clin. Invest. 121:2554 -2569.
64. Mack EA, Kallal LE, Demers DA, Biron CA. 2011. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. MBio 2:e00169-11. doi:10.1128/mBio.00169-11.
65. Malmgaard L, Salazar-Mather TP, Lewis CA, Biron CA. 2002. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76:4520-4525.
66. Matloubian M, Concepcion RJ, Ahmed R. 1994. CD4+ T cells arerequired to sustain CD8+cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
67. Matsumoto M, et al. 1999. Activation of the transcription factor ISGF3 by interferon-gamma. Biol. Chem. 380:699 -703.
68. Matullo CM, O'Regan KJ, Hensley H, Curtis M, Rall GF. 2010. Lymphocytic choriomeningitis virus-induced mortality in mice is triggered by edema and brain herniation. J. Virol. 84:312-320.
69. Meier KC, Gardner CL, Khoretonenko MV, Klimstra WB, Ryman KD. 2009. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog. 5:e1000614. doi:10.1371/ journal.ppat.1000614.
70. Merigan TC, Oldstone MB, Welsh RM. 1977. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 268:67- 68.
71. Miyagi T, et al. 2007. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204:2383-2396.
72. Montoya M, Edwards MJ, Reid DM, Borrow P. 2005. Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN. J. Immunol. 174:1851-1861.
73. Morrow AN, Schmeisser H, Tsuno T, Zoon KC. 2011. A novel role for IFN-stimulated gene factor 3II in IFN-gamma signaling and induction of antiviral activity in human cells. J. Immunol. 186:1685-1693.
74. Muller U, et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918 -1921.
75. Nansen A, et al. 1998. Role of interferon-gamma in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-gamma knock-out mice. J. Neuroimmunol. 86:202-212.
76. Neufert C, et al. 2007. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur. J. Immunol. 37:1809 -1816.
77. Nguyen KB, et al. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation ofNKcell responses to viral infection. J. Immunol. 169:4279-4287.
78. Nishibori T, Tanabe Y, Su L, David M. 2004. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199:25-34.
79. Oldstone MB, et al. 1999. Use of a high-affinity peptide that aborts MHC-restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo. Virology 256:246 -257.
80. Ou R, Zhou S, Huang L, Moskophidis D. 2001. Critical role for alpha/ beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75:8407- 8423.
81. Ouaked N, et al. 2009. Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J. Immunol. 182:1041-1049.
82. Ousman SS, Campbell IL. 2005. Regulation of murine interferon regulatory factor gene expression in the central nervous system determined by multiprobe RNase protection assay. Methods Mol. Med. 116:115- 134.
83. Ousman SS, Wang J, Campbell IL. 2005. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 79:7514 -7527.
84. Park C, Li S, Cha E, Schindler C. 2000. Immune response in Stat2 knockout mice. Immunity 13:795- 804.
85. Pasieka TJ, Lu B, Leib DA. 2008. Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J. Virol. 82:6052- 6055.
86. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8 -32.
87. Rahemtulla A, et al. 1991. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353:180 -184.
88. Ritchie KJ, et al. 2004. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10:1374 -1378.
89. Roebroek RM, Postma BH, Dijkstra UJ. 1994. Aseptic meningitis caused by the lymphocytic choriomeningitis virus. Clin. Neurol. Neurosurg. 96:178 -180.
90. Rousseau MC, Saron MF, Brouqui P, Bourgeade A. 1997. Lymphocytic choriomeningitis virus in southern France: four case reports and a review of the literature. Eur. J. Epidemiol. 13:817- 823.
91. Sandberg K, et al. 1994. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta. J. Immunol. 153:220 -231.
92. Sen GC, Ransohoff RM. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:57-102.
93. Seo YJ, Hahm B. 2010. Type I interferon modulates the battle of host immune system against viruses. Adv. Appl. Microbiol. 73:83-101.
94. Shornick LP, et al. 2008. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J. Immunol. 180:3319 -3328.
95. Shresta S, et al. 2005. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 175:3946 -3954.
96. Shuai K, Schindler C, Prezioso VR, Darnell JE, Jr. 1992. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kDDNA binding protein. Science 258:1808 -1812.
97. Siegal FP, et al. 1999. The nature of the principal type 1 interferonproducing cells in human blood. Science 284:1835-1837.
98. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
99. van Boxel-Dezaire AH, Rani MR, Stark GR. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361-372.
100. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792- 4796.
101. VanDeusen JB, et al. 2006. STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur. J. Immunol. 36:623- 630.
102. Vanzee BE, et al. 1975. Lymphocytic choriomeningitis in university hospital personnel. Clinical features. Am. J. Med. 58:803- 809.
103. Villarino AV, Gallo E, Abbas AK. 2010. STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms. J. Immunol. 185:6461- 6471.
104. Wacher C, et al. 2007. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81:860-871.
105. Walsh CM, et al. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. U. S. A. 91:10854 -10858.
106. Warkel RL, et al. 1973. Fatal acute meningoencephalitis due to lymphocytic choriomeningitis virus. Neurology 23:198 -203.
107. Wright R, et al. 1997. Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics 100:E9. doi:10.1542/peds.100.1.e9.
108. Zhou S, et al. 2010. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 84:9452-9462.
109. Zimmermann A, et al. 2005. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J. Exp. Med. 201:1543-1553.
110. Zinkernagel RM, Doherty PC. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51-177.
111. Zinkernagel RM, Doherty PC. 1997. The discovery of MHC restriction. Immunol. Today 18:14 -17.
112. Zornetzer GA, et al. 2010. Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J. Virol. 84:11297-11309.